AstraZeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC
1:17-cv-01795
Overview
Parties
Movant
AstraZeneca Pharmaceuticals LP NPE (Individual / Inventor)
Represented By
5 Attorneys ListedO'Melveny & Myers LLP
7 Times Square, Times Square Tower, New York, NY 10036
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Defendant
AstraZeneca AB NPE (Individual / Inventor)
Represented By
4 Attorneys ListedO'Melveny & Myers LLP
7 Times Square, Times Square Tower, New York, NY 10036
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Fresenius Kabi USA, LLC Operating Company
Represented By
4 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Phillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Phillips, Goldman, McLaughlin & Hall, P.A.
Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street
Plaintiff
AstraZeneca UK Limited NPE (University / Research)
Represented By
4 Attorneys ListedO'Melveny & Myers LLP
7 Times Square, Times Square Tower, New York, NY 10036
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇺🇸 United States | US Continuation / Sibling | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → | |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → |
Fresenius Kabi USA, LLC v. AstraZeneca AB
Fresenius Kabi USA,LLC v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
InnoPharma Licensing LLC et al. v. AstraZeneca AB
Mylan Pharmaceuticals Inc. v. AstraZeneca AB
Mylan Pharmaceuticals Inc. et al. v. AstraZeneca AB et al.
Mylan Pharmaceuticals Inc. v. AstraZeneca AB
Mylan Pharmaceuticals Inc. v. AstraZeneca AB
AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC
ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.
Patents Involved
There are 4 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6774122
Formulation
|
Filed: 2001-01-09
Issued: 2004-08-10
|
Expired (Term Ended)
Expires: 2021-01-09
|
|
|
US7456160
Formulation
|
Filed: 2004-06-22
Issued: 2008-11-25
|
Expired (Term Ended)
Expires: 2023-06-01
|
|
|
US8329680
Formulation
|
Filed: 2008-10-15
Issued: 2012-12-11
|
Expired (Term Ended)
Expires: 2025-05-26
|
|
|
US8466139
Formulation
|
Filed: 2012-09-04
Issued: 2013-06-18
|
Active (5.8 yrs remaining)
Expires: 2032-09-04
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
2
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings